Dr. Muhammad Faisal Khalid, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 401 Market St Ste 200, Steubenville, OH 43952 Phone: 740-314-8424 Fax: 740-672-5281 |
Ramana Murty, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 401 Market St Ste 720, Steubenville, OH 43952 Phone: 740-284-5551 Fax: 740-346-4048 |
Rafael L Schmulevich, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4100 Johnson Rd Ste 207, Steubenville, OH 43952 Phone: 740-266-9169 Fax: 740-266-6933 |
Charn S Nandra, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 401 Market St Ste 902, Steubenville, OH 43952 Phone: 740-284-5522 Fax: 740-284-5523 |
Sathish Magge, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 401 Market St Ste 200, Steubenville, OH 43952 Phone: 740-282-5000 Fax: 740-282-5233 |
News Archive
Cultural "lore" outweighs criminal law when Indigenous drivers in regional and remote communities get behind the wheel drunk, a new study by Queensland University of Technology has found.
Premier Purchasing Partners, LP, today announced new agreements for exam gloves have been awarded to Cardinal Health of Waukegan, Ill.; Digitcare Corporation of Los Angeles, a minority business enterprise; Innovative Healthcare Corporation of Sand Springs, Okla., a veteran business enterprise; Kimberly-Clark Corporation of Roswell, Ga.; Medgluv Inc. of Fort Lauderdale, Fla., a minority business enterprise; Medline Industries Inc. of Mundelein, Ill.; and Tronex Company of Parsippany, N.J., a minority business enterprise.
Researchers at the University of Rostock in Germany have developed a model of coronavirus disease 2019 (COVID-19) transmission that considers subdivisions of age and sex to provide better insights into the impact that increased contact rates might have on the risk of infection and mortality.
The authors write: "We found that if a hospital's surgical inpatient volume is not growing, such a program results in negative cash flow. We also found that if a hospital's surgical volume is growing, and if the hospital can sufficiently reduce the average length-of-stay for surgical patients without complications, the cash flow could be positive. We recommend that hospitals with limited growth prospects that are nonetheless contemplating a surgical complication reduction program establish agreements with payers to share in any savings generated by the program."
"The results of this study are counter to most expectations," said Dr. Brachman, Director of Radiation Oncology at Barrow and St. Joseph's. "Bevacizumab had been shown in earlier studies to be an effective drug in the treatment of patients with recurrent disease. But, on newly diagnosed patients, it did not, in fact, prolong survival."
› Verified 4 days ago